Roble Belko & Company’s iShares iBonds Dec 2021 Term Corporate ETF IBDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-10,119
Closed -$250K 380
2021
Q3
$250K Hold
10,119
0.05% 82
2021
Q2
$251K Hold
10,119
0.06% 88
2021
Q1
$251K Hold
10,119
0.06% 83
2020
Q4
$252K Hold
10,119
0.07% 78
2020
Q3
$253K Hold
10,119
0.07% 77
2020
Q2
$254K Hold
10,119
0.08% 79
2020
Q1
$249K Hold
10,119
0.08% 78
2019
Q4
$253K Hold
10,119
0.07% 83
2019
Q3
$253K Hold
10,119
0.07% 73
2019
Q2
$252K Hold
10,119
0.08% 72
2019
Q1
$250K Hold
10,119
0.09% 69
2018
Q4
$246K Hold
10,119
0.09% 67
2018
Q3
$246K Hold
10,119
0.09% 54
2018
Q2
$247K Hold
10,119
0.09% 55
2018
Q1
$248K Hold
10,119
0.1% 55
2017
Q4
$251K Hold
10,119
0.1% 52
2017
Q3
$253K Hold
10,119
0.11% 48
2017
Q2
$253K Buy
10,119
+2,002
+25% +$50K 0.12% 45
2017
Q1
$201K Buy
8,117
+6,067
+296% +$150K 0.1% 50
2016
Q4
$51K Buy
+2,050
New +$51.1K 0.03% 98

Other funds holding IBDM

Roble Belko & Company's IBDM Position: Q4 2021 in Review

Roble Belko & Company sold out of iShares iBonds Dec 2021 Term Corporate ETF (IBDM) in Q4 2021, closing a stake of 10,119 shares — an estimated $250K sold.

Roble Belko & Company first reported a position in IBDM in Q4 2016 and held it in 20 quarters. The position peaked at $254K in Q2 2020. 1 fund tracked by Wall St. Rank holds IBDM as of Q4 2021.

  • Roble Belko & Company reported no remaining iShares iBonds Dec 2021 Term Corporate ETF position as of Q4 2021 after selling out during the quarter.
  • Roble Belko & Company sold 10,119 iShares iBonds Dec 2021 Term Corporate ETF shares in Q4 2021, an estimated $250K.
  • Roble Belko & Company first reported a position in iShares iBonds Dec 2021 Term Corporate ETF in Q4 2016 and held it in 20 quarters.
  • Roble Belko & Company's iShares iBonds Dec 2021 Term Corporate ETF position peaked at $254K in Q2 2020.
  • 1 fund tracked by Wall St. Rank held iShares iBonds Dec 2021 Term Corporate ETF as of Q4 2021.

Based on Roble Belko & Company's 13F filing for Q4 2021, filed 7 Feb 2022.